User profiles for Alicia Zhou

Alicia Yiran Zhou

Color Genomics
Verified email at color.com
Cited by 15987

[HTML][HTML] The epithelial-mesenchymal transition generates cells with properties of stem cells

…, W Guo, MJ Liao, EN Eaton, A Ayyanan, AY Zhou… - Cell, 2008 - cell.com
The epithelial-mesenchymal transition (EMT) is a key developmental program that is often
activated during cancer invasion and metastasis. We here report that the induction of an EMT …

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

…, K Komurov, AY Zhou… - Proceedings of the …, 2010 - National Acad Sciences
The epithelial-to-mesenchymal transition (EMT) produces cancer cells that are invasive,
migratory, and exhibit stem cell characteristics, hallmarks of cells that have the potential to …

Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

…, K Kessenbrock, KD Prummel, Y Yu, K Takai, A Zhou… - Nature, 2015 - nature.com
Despite major advances in understanding the molecular and genetic basis of cancer,
metastasis remains the cause of >90% of cancer-related mortality 1 . Understanding metastasis …

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

…, M Brooks, G Schwaninger, A Zhou… - Proceedings of the …, 2007 - National Acad Sciences
The metastatic spread of epithelial cancer cells from the primary tumor to distant organs mimics
the cell migrations that occur during embryogenesis. Using gene expression profiling, we …

[HTML][HTML] Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions

…, CA Cassa, M Lebo, K Ng, ES Lander, AY Zhou… - Nature …, 2020 - nature.com
Genetic variation can predispose to disease both through (i) monogenic risk variants that
disrupt a physiologic pathway with large effect on disease and (ii) polygenic risk that involves …

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer

R Camarda, AY Zhou, RA Kohnz, S Balakrishnan… - Nature medicine, 2016 - nature.com
Expression of the oncogenic transcription factor MYC is disproportionately elevated in triple-negative
breast cancer (TNBC), as compared to estrogen receptor–, progesterone receptor– …

[PDF][PDF] Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKɛ promotes cell transformation

JE Hutti, RR Shen, DW Abbott, AY Zhou, KM Sprott… - Molecular cell, 2009 - cell.com
The noncanonical IKK family member IKKɛ is essential for regulating antiviral signaling
pathways and is a recently discovered breast cancer oncoprotein. Although several IKKɛ targets …

[PDF][PDF] Structure and ubiquitination-dependent activation of TANK-binding kinase 1

D Tu, Z Zhu, AY Zhou, C Yun, KE Lee, AV Toms, Y Li… - Cell reports, 2013 - cell.com
Upon stimulation by pathogen-associated inflammatory signals, TANK-binding kinase 1 (TBK1)
induces type I interferon expression and modulates nuclear factor κB (NF-κB) signaling. …

PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression

D Horiuchi, R Camarda, AY Zhou, C Yau… - Nature medicine, 2016 - nature.com
Triple-negative breast cancer (TNBC), in which cells lack expression of the estrogen receptor
(ER), the progesterone receptor (PR) and the ERBB2 (also known as HER2) receptor, is …

[HTML][HTML] Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California

…, AS Gliwa, E Torres, N Brazer, A Zhou… - Nature …, 2022 - nature.com
Associations between vaccine breakthrough cases and infection by different SARS coronavirus
2 (SARS-CoV-2) variants have remained largely unexplored. Here we analysed SARS-…